Corbus Pharmaceuticals Holdings Inc (CRBP)
38.36
+1.11
(+2.98%)
USD |
NASDAQ |
May 02, 14:09
Corbus Pharmaceuticals Holdings Cash from Financing (Quarterly): -1.905M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.905M |
| September 30, 2023 | -0.8205M |
| June 30, 2023 | 0.0177M |
| March 31, 2023 | -0.113M |
| December 31, 2022 | 0.2343M |
| September 30, 2022 | -0.1107M |
| June 30, 2022 | -0.3301M |
| March 31, 2022 | -0.3271M |
| December 31, 2021 | 0.7679M |
| September 30, 2021 | -0.1027M |
| June 30, 2021 | -0.2556M |
| March 31, 2021 | 60.41M |
| December 31, 2020 | 21.74M |
| September 30, 2020 | 46.73M |
| June 30, 2020 | 43.47M |
| March 31, 2020 | 42.93M |
| December 31, 2019 | 0.7527M |
| September 30, 2019 | -0.0246M |
| June 30, 2019 | -0.1912M |
| March 31, 2019 | 37.93M |
| Date | Value |
|---|---|
| December 31, 2018 | 0.4032M |
| September 30, 2018 | -0.0644M |
| June 30, 2018 | -0.0473M |
| March 31, 2018 | 11.13M |
| December 31, 2017 | 35.59M |
| September 30, 2017 | -0.058M |
| June 30, 2017 | -0.138M |
| March 31, 2017 | 40.61M |
| December 31, 2016 | 1.671M |
| September 30, 2016 | 0.1552M |
| June 30, 2016 | 14.99M |
| March 31, 2016 | -0.0702M |
| December 31, 2015 | 0.162M |
| September 30, 2015 | 6.418M |
| June 30, 2015 | 4.267M |
| March 31, 2015 | -0.0093M |
| December 31, 2014 | 0.0474M |
| September 30, 2014 | -0.3331M |
| June 30, 2014 | 8.671M |
| March 31, 2014 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.905M
Minimum
Dec 2023
60.41M
Maximum
Mar 2021
11.20M
Average
-0.0246M
Median
Sep 2019
Cash from Financing (Quarterly) Benchmarks
| Spectral AI Inc | 4.52M |
| Panbela Therapeutics Inc | 4.749M |
| AIM ImmunoTech Inc | 0.147M |
| Protalix BioTherapeutics Inc | 0.00 |
| Armata Pharmaceuticals Inc | -0.043M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.009M |
| Cash from Investing (Quarterly) | 10.39M |
| Free Cash Flow | -36.10M |
| Free Cash Flow Per Share (Quarterly) | -1.358 |
| Free Cash Flow Yield | -21.75% |